The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.
Cells
; 13(5)2024 Feb 20.
Article
in En
| MEDLINE
| ID: mdl-38474332
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridinium Compounds
/
Testicular Neoplasms
/
Cisplatin
/
Neoplasms, Germ Cell and Embryonal
/
Cyclic N-Oxides
/
Indolizines
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Cells
Year:
2024
Document type:
Article
Affiliation country:
Italia
Country of publication:
Suiza